[19] This study was limited by failure to establish the reliability of the bililabstix as a test for occult blood, failure to blind the test results, and retrospective patient classification.
ORLANDO -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according to a survey study. Among ...
In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved. While new, less-invasive blood tests ...